西洛他唑对 2 型糖尿病患者预防大血管疾病的长期影响。
Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus.
机构信息
Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
出版信息
Diabetes Res Clin Pract. 2011 Jan;91(1):e11-4. doi: 10.1016/j.diabres.2010.09.009. Epub 2010 Oct 8.
Abstract
We analyzed the medical records of 884 type 2 DM patients who were taking different antiplatelet agents for more than 2 years. Based on the records, occurrences of cardiovascular events for 10 years were evaluated. The composite disease-free survival rate for cilostazol monotherapy group was similar to aspirin subgroup (p=0.133).
摘要
我们分析了 884 例服用不同抗血小板药物超过 2 年的 2 型糖尿病患者的病历。根据这些记录，评估了 10 年内心血管事件的发生情况。西洛他唑单药治疗组与阿司匹林亚组的复合无病生存率相似（p=0.133）。
Zotero 插件